Table of Contents Understanding GLP-1 Medications and Thyroid Cancer Concerns What the Clinical Evidence Shows About GLP-1 and Thyroid Risk Thyroid Cancer Warning: Who Should Exercise Caution with GLP-1 Medications Monitoring and Safety Guidance for GLP-1 Users in the UK Discussing Thyroid Cancer Risk with Your Healthcare Provider Scientific References Frequently Asked Questions Understanding GLP-1 Medications and Thyroid Cancer Concerns Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications increasingly prescribed in the UK for type 2 diabetes management and, more recently, for weight management
However, the lower dose of semaglutide used and a focus on patient-reported outcomes rather than on cardiovascular events are limitations of STEP-HFpEF DM
McConnells sign, the presence of RV dilation and hypokinesis of the mid and basal portions of the RV with apical sparing (as opposed to global RV dysfunction), has been reported to be specific for acute RV strain, although it may not differentiate well between acute strain from PE versus acute strain from RV infarction.37, 4648
When used in the morning, it is preferable to apply sunscreen after moisturizer to protect the skin and maintain its balanced appearance
Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis